Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)

Detalhes bibliográficos
Autor(a) principal: Gutierres, Vania Ortega [UNESP]
Data de Publicação: 2015
Outros Autores: Campos, Michel Leandro [UNESP], Arcaro, Carlos Alberto [UNESP], Assis, Renata Pires [UNESP], Baldan-Cimatti, Helen Mariana [UNESP], Peccinini, Rosangela Gonçalves [UNESP], Paula-Gomes, Silvia, Kettelhut, Isis Carmo, Baviera, Amanda Martins [UNESP], Brunetti, Iguatemy Lourenço [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://www.hindawi.com/journals/ecam/2015/678218/
http://hdl.handle.net/11449/129364
Resumo: This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity.
id UNSP_03ac1042876fb956b04e78d772c2ee3a
oai_identifier_str oai:repositorio.unesp.br:11449/129364
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Faculdade de Ciencias Farmaceuticas (FCFAr-UNESP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Biochemistry and Immunology, School of Medicine, University of São Paulo (USP), Avenida Bandeirantes 3900, 14040-900 Ribeirão Preto, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01, 14801-902 Araraquara, SP, BrazilDepartment of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01, 14801-902 Araraquara, SP, BrazilHindawi Publishing CorporationUniversidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Gutierres, Vania Ortega [UNESP]Campos, Michel Leandro [UNESP]Arcaro, Carlos Alberto [UNESP]Assis, Renata Pires [UNESP]Baldan-Cimatti, Helen Mariana [UNESP]Peccinini, Rosangela Gonçalves [UNESP]Paula-Gomes, SilviaKettelhut, Isis CarmoBaviera, Amanda Martins [UNESP]Brunetti, Iguatemy Lourenço [UNESP]2015-10-21T20:55:59Z2015-10-21T20:55:59Z2015-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-13application/pdfhttp://www.hindawi.com/journals/ecam/2015/678218/Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015.1741-427Xhttp://hdl.handle.net/11449/12936410.1155/2015/678218WOS:000355808600001WOS000355808600001.pdf10667434239290933736475025187750Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEvidence-based Complementary And Alternative Medicine2.064info:eu-repo/semantics/openAccess2024-06-24T14:52:03Zoai:repositorio.unesp.br:11449/129364Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T23:57:02.217727Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
title Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
spellingShingle Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
Gutierres, Vania Ortega [UNESP]
title_short Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
title_full Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
title_fullStr Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
title_full_unstemmed Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
title_sort Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
author Gutierres, Vania Ortega [UNESP]
author_facet Gutierres, Vania Ortega [UNESP]
Campos, Michel Leandro [UNESP]
Arcaro, Carlos Alberto [UNESP]
Assis, Renata Pires [UNESP]
Baldan-Cimatti, Helen Mariana [UNESP]
Peccinini, Rosangela Gonçalves [UNESP]
Paula-Gomes, Silvia
Kettelhut, Isis Carmo
Baviera, Amanda Martins [UNESP]
Brunetti, Iguatemy Lourenço [UNESP]
author_role author
author2 Campos, Michel Leandro [UNESP]
Arcaro, Carlos Alberto [UNESP]
Assis, Renata Pires [UNESP]
Baldan-Cimatti, Helen Mariana [UNESP]
Peccinini, Rosangela Gonçalves [UNESP]
Paula-Gomes, Silvia
Kettelhut, Isis Carmo
Baviera, Amanda Martins [UNESP]
Brunetti, Iguatemy Lourenço [UNESP]
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Gutierres, Vania Ortega [UNESP]
Campos, Michel Leandro [UNESP]
Arcaro, Carlos Alberto [UNESP]
Assis, Renata Pires [UNESP]
Baldan-Cimatti, Helen Mariana [UNESP]
Peccinini, Rosangela Gonçalves [UNESP]
Paula-Gomes, Silvia
Kettelhut, Isis Carmo
Baviera, Amanda Martins [UNESP]
Brunetti, Iguatemy Lourenço [UNESP]
description This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity.
publishDate 2015
dc.date.none.fl_str_mv 2015-10-21T20:55:59Z
2015-10-21T20:55:59Z
2015-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.hindawi.com/journals/ecam/2015/678218/
Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015.
1741-427X
http://hdl.handle.net/11449/129364
10.1155/2015/678218
WOS:000355808600001
WOS000355808600001.pdf
1066743423929093
3736475025187750
url http://www.hindawi.com/journals/ecam/2015/678218/
http://hdl.handle.net/11449/129364
identifier_str_mv Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015.
1741-427X
10.1155/2015/678218
WOS:000355808600001
WOS000355808600001.pdf
1066743423929093
3736475025187750
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Evidence-based Complementary And Alternative Medicine
2.064
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1-13
application/pdf
dc.publisher.none.fl_str_mv Hindawi Publishing Corporation
publisher.none.fl_str_mv Hindawi Publishing Corporation
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129566012604416